Back to News
Market Impact: 0.34

Nebius Stock Had a Record Month in May. Is It Too Late to Buy?

Artificial IntelligenceTechnology & InnovationCorporate Guidance & OutlookCompany FundamentalsAnalyst InsightsMarket Technicals & Flows
Nebius Stock Had a Record Month in May. Is It Too Late to Buy?

Nebius reported just $105 million in Q2 2025 sales, but management raised guidance to an annualized revenue run rate of up to $1.1 billion and then ended the period at $1.25 billion. The company now expects over $3 billion of revenue in 2026 and more than 4 GW of contracted capacity by end-2026, with its record pipeline more than quadrupling quarter over quarter in Q1. The article is constructive on business momentum but cautions that the stock has already priced in a lot of growth, especially after a 67.2% monthly surge.

Analysis

NBIS is transitioning from a story stock to a capacity-constrained infrastructure compounder, but the market is already discounting a near-perfect execution path. The second-order dynamic is that each incremental contract announcement now has less valuation impact unless it is paired with proof that power, networking, and GPU supply can be converted into sustained gross margin rather than just headline revenue.

The key risk is not demand; it is monetization quality and timing. A multi-gigawatt contract backlog is impressive, but it also implies heavy upfront capex and a long lag between booked capacity and cash yield, so any slip in commissioning, utilization, or customer concentration could compress the multiple quickly over the next 1-3 quarters. In other words, the stock is likely more sensitive to operating cadence than to absolute pipeline growth from here.

Competitively, NBIS’s success supports the broader AI infrastructure complex by validating inference demand and the market’s willingness to pay for scarce compute. That should be a modest tailwind for NVDA on accelerators and networking, but a larger hidden risk for any adjacent hyperscaler or private-cloud operator that needs to secure power and data-center slots at rising cost. The consensus may be underestimating how quickly supply-side bottlenecks become the binding constraint in inference, which favors the few firms that can lock power early and punish the rest with delayed deployments.

The contrarian setup is that the strongest operational data is also the clearest setup for a drawdown: the stock can be right on fundamentals and still underperform if the next few quarters merely confirm rather than beat expectations. This is a classic "great company, bad entry point" profile, where forward returns likely depend more on a pullback or a reset in growth assumptions than on chasing momentum at current levels.